IP Library Granted Patent US 9,435,790
Granted Patent B2
US 9,435,790 · App. 13/142,046 · Granted Sep 6, 2016

Cell separation technique

Inventors: Christopher Gregory (Edinburgh, GB); John Pound (Edinburgh, GB)
Assignee: Grampian Biopartners Limited
G01N33/5032G01N2400/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,435,790
App. No.
13/142,046
Granted
Sep 6, 2016
Kind
B2
Abstract

In a first aspect, the present invention provides a method of removing non-viable cells from a cell population, said method comprising contacting a cell population with a compound under conditions suitable to permit binding between the compound and any non-viable cells present in the cell culture and removing at least some of the compound from said cell population. The invention further provides compositions suitable for use in these methods, further uses of such compositions and various other systems and kits.

Claims (16)

1. A method of improving the viability and/or productivity of a cell in order to generate improved yields of cells or particular products expressed by a cell culture, the method comprising the steps of:

contacting a cell population of the culture with carboxylated and/or amino dextran under conditions suitable to permit binding between the carboxylated and/or amino dextran and any dead cells or cells undergoing programmed cell death present in the cell culture, wherein the carboxylated and/or amino dextran is packed or provided in a column to which the cell population is added;

removing at least some of the cell-bound carboxylated and/or amino dextran from said cell culture; and

culturing the cell culture to provide an improved yield of cells and/or improved product expressed by the cells of the cell culture.

2. A method of improving the viability and/or productivity of a cell in order to generate improved yields of cells or particular products expressed by a cell culture, the method comprising the steps of:

contacting a cell population of the culture with carboxylated and/or amino dextran under conditions suitable to permit binding between the carboxylated and/or amino dextran and any dead cells or cells undergoing programmed cell death present in the cell culture, wherein the carboxylated and/or amino dextran is adhered, bound, immobilized and/or otherwise associated with a scaffold material to be added to the cell population;

removing at least some of the cell-bound carboxylated and/or amino dextran from said cell culture; and

culturing the cell culture to provide an improved yield of cells and/or improved product expressed by the cells of the culture.

3. A method of improving the viability and/or productivity of a cell in order to generate improved yields of cells or particular products expressed by a cell culture, the method comprising the steps of:

contacting a cell population of the culture with carboxylated and/or amino dextran under conditions suitable to permit binding between the carboxylated and/or amino dextran and any dead cells or cells undergoing programmed cell death present in the cell culture;

removing at least some of the cell-bound carboxylated and/or amino dextran from said cell culture, wherein at least some of the cell-bound carboxylated and/or amino dextran is removed from the cell population by filtration, density separation, flow cytometry/cell sorting and/or affinity chromatography techniques; and

culturing the cell culture to provide an improved yield of cells and/or improved product expressed by the cells of the cell culture.

4. A method of improving the viability and/or productivity of a cell in order to generate improved yields of cells or particular products expressed by a cell culture, the method comprising the steps of:

contacting a cell population of the culture with carboxylated and/or amino dextran under conditions suitable to permit binding between the carboxylated and/or amino dextran and any dead cells or cells undergoing programmed cell death present in the cell culture, wherein the carboxylated and/or amino dextran is provided in the form of a micro- or nanoparticle and the micro- or nanoparticles further comprise a magnetic material;

removing at least some of the cell-bound carboxylated and/or amino dextran from said cell culture, wherein at least some of the cell-bound carboxylated and/or amino dextran is removed from the cell population via the application of a magnetic field; and

culturing the cell culture to provide an improved yield of cells and/or improved product expressed by the cells of the cell culture wherein the carboxylated and/or amino dextran is provided in the form of a micro- or nanoparticle, wherein the micro- or nanoparticles further comprise a magnetic material and at least some of the cell-bound carboxylated and/or amino dextran is removed from the cell population via the application of a magnetic field.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2017
From: GRAMPIAN BIOPARTNERS LIMITED
To: PHARMACELLS LIMITED
Reel/Frame 041823/0780 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2015
From: IMMUNOSOLV LIMITED
To: GRAMPIAN BIOPARTNERS LIMITED
Reel/Frame 035681/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2015
From: IMMUNSOLV LIMITED
To: GRAMPIAN BIOPARTNERS LIMITED
Reel/Frame 035421/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: CHRISTOPHER, GREGORY; POUND, JOHN
To: IMMUNOSOLV LIMITED
Reel/Frame 030288/0004 →
Priority Claims (1)
GB 0823553.3 · Dec 24, 2008 · national
Continuity (1)
Related Publication 20110256581A1 · Oct 20, 2011